Review

Nature Reviews Drug Discovery 4, 569-580 (July 2005) | doi:10.1038/nrd1777

Ageing and metabolism: drug discovery opportunities

Rory Curtis1, Bard J. Geesaman1 & Peter S. DiStefano1  About the authors

Top

There has recently been significant progress in our understanding of the mechanisms that regulate ageing, and it has been shown that changes in single genes can dramatically extend lifespan and increase resistance to many diseases. Furthermore, many of these genes belong to evolutionarily conserved pathways that also control energy metabolism. In this review, we describe the shared molecular machinery that regulates ageing and energy metabolism. Although drugs to slow ageing face severe regulatory hurdles, it is likely that an understanding of ageing pathways will help to identify novel drug targets to treat metabolic disorders and other age-related diseases.

Author affiliations

  1. Elixir Pharmaceuticals, One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, USA.

Correspondence to: Peter S. DiStefano1 Email: pdistefano@elixirpharm.com

Published online 24 June 2005

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Ageing When less is more

Nature News and Views (31 May 2007)

Ageing A message from the gonads

Nature News and Views (27 May 1999)

See all 5 matches for News And Views

Extra navigation

Search PubMed for

Open Innovation Challenges

naturejobs

Advertisement